This weekend, Jacksonville Beach will play host to one of the best parties in surfing and the kind of gathering that reminds you why you fell in love with surfing in the first place, an event dubbed, ...

WAYNE, Pa. - Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical-stage biotech company with a market capitalization of $156 million, announced Monday the appointment of Kevin R. Lind to its Board of ...

Laguna Beach surfer Avalon Gall entered the US Open of Surfing longboard contest as a wildcard, never imagining she would make the podium with her first-ever big win. “It’s very surreal, I’m just ...

A family tragedy has inspired a West Australian grandfather to become the country's oldest surfing champion. Some of John Haddow's fondest memories are riding his longboard while feeling his ...

In this video, I demonstrate how to make a skateboard from acrylic, utilizing leftover materials from a side table project. The result is a crystal clear longboard that highlights a unique see-through ...

How to Make a Longboard // Scrap Project // DIY Project // Beginner Woodworking Project Mary Trump issues warning on long-term impact of Donald Trump move Great white shark sneaks up on Cape Cod ...

Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to gain access to its novel epilepsy drug. The acquisition announced Monday ...

Two Southern California surfers have claimed the 2024 World Surf League’s World Longboard Championship – a second win for Dana Point native Rachael Tilly and a fourth for San Diego’s Taylor Jensen.

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction data, ...

Lundbeck announced this week that it will acquire Longboard Pharmaceuticals in a $2.6 billion deal, picking up the epilepsy drug bexicaserin in the process. The move — the largest to date for the ...

Shares of Longboard Pharmaceuticals Inc. were soaring more than 51% on Monday after the announcement of H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical ...

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical development ...